Skip to main content

A PILOT STUDY TO EVALUATE AN INTRARENAL INJECTION FOR THE MANAGEMENT OF CHRONIC KIDNEY DISEASE

Principal Investigator

Shelly Vaden

Description

Pilot study to evaluate the field safety and effectiveness of an ultrasound-guided bilateral intrarenal injection of a chemokine for the management of IRIS stages 2 and 3 chronic kidney disease in felines.

Testing Requirements

Owner must be willing to bring their cat to the Veterinary Hospital for 8 study visits over the course of 10 months. They must complete a weekly questionnaire at home (38 weeks) and cats must eat a renal prescription diet throughout the study. This is a placebo-controlled study but placebo cats will have the option of receiving treatment if they have disease progression. Treatment consists of a one-time ultrasound guided injection into each kidney.

Enrollment Start

02/01/2022

Enrollment Finish

02/01/2024

Eligibility

≥ 7 years old, indoor only, diagnosed with IRIS Stages 2 and 3 CKD, good general health (other than CKD)

Flyer

View

Contact

Katelyn Bennett: 919-515-8380 OR cvmclinicalstudies@ncsu.edu